BB&T Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.81M Sell
14,055
-242
-2% -$71.6K 0.03% 434
2019
Q2
$4.47M Buy
14,297
+1,914
+15% +$637K 0.04% 410
2019
Q1
$5.08M Sell
12,383
-377
-3% -$155K 0.05% 378
2018
Q4
$4.76M Buy
12,760
+227
+2% +$83.1K 0.05% 369
2018
Q3
$5.06M Buy
12,533
+1,093
+10% +$416K 0.05% 390
2018
Q2
$3.95M Buy
11,440
+4,038
+55% +$1.26M 0.04% 430
2018
Q1
$2.55M Buy
7,402
+4,226
+133% +$1.47M 0.03% 522
2017
Q4
$1.19M Buy
3,176
+145
+5% +$58.7K 0.02% 684
2017
Q3
$1.35M Buy
3,031
+535
+21% +$255K 0.02% 647
2017
Q2
$1.23M Buy
2,496
+864
+53% +$378K 0.02% 658
2017
Q1
$632K Buy
+1,632
New +$605K 0.01% 808

Other funds holding REGN